中国骨与关节外科
中國骨與關節外科
중국골여관절외과
CHINESE BONE AND JOINT SURGERY
2013年
3期
214-218
,共5页
股骨近端%骨转移癌%外科治疗%重建%内固定%假体置换
股骨近耑%骨轉移癌%外科治療%重建%內固定%假體置換
고골근단%골전이암%외과치료%중건%내고정%가체치환
proximal femur%bone metastases%surgical treatment%reconstruction%internal fixation%prosthesis replacement
股骨近端转移癌切除重建方法的选择需要综合考虑多种因素,其中原发肿瘤的生物学行为、股骨病变破坏范围、患者一般状况以及围手术期风险是最值得关注的.目的:比较股骨近端转移癌患者接受髓内针/接骨板内固定和假体置换的围手术期安全性和早期功能.方法:回顾性分析2003年1月至2011年12月接受手术治疗的88例股骨近端转移性肿瘤患者的围手术期临床资料(随访资料完整),年龄15~87岁,中位年龄58岁.患者平均预期生存期10.26个月.按手术重建方式分为髓内针/接骨板内固定组33例;假体置换组55例.比较两组患者的术中出血量、手术时间、围手术期并发症和术后早期功能.结果:随访时间为1~44个月,平均8.74个月.两组患者手术时间(P=0.173)、围手术期并发症(χ2=0.014, P=0.905)和术后早期功能(P=0.777)等围手术期指标无统计学差异.髓内针/接骨板内固定组1例于术后3周死于多器官衰竭,假体置换组患者术中出血量显著低于髓内针/接骨板内固定组(P=0.043).结论:假体置换和髓内针/接骨板内固定均为股骨近端转移癌的重要手术方式,两种重建方法的围手术期并发症和术后早期功能无统计学差异,但鉴于髓内针/接骨板内固定的远期失败率较高,对预期生存期较长的患者来说,假体置换是更好的选择.
股骨近耑轉移癌切除重建方法的選擇需要綜閤攷慮多種因素,其中原髮腫瘤的生物學行為、股骨病變破壞範圍、患者一般狀況以及圍手術期風險是最值得關註的.目的:比較股骨近耑轉移癌患者接受髓內針/接骨闆內固定和假體置換的圍手術期安全性和早期功能.方法:迴顧性分析2003年1月至2011年12月接受手術治療的88例股骨近耑轉移性腫瘤患者的圍手術期臨床資料(隨訪資料完整),年齡15~87歲,中位年齡58歲.患者平均預期生存期10.26箇月.按手術重建方式分為髓內針/接骨闆內固定組33例;假體置換組55例.比較兩組患者的術中齣血量、手術時間、圍手術期併髮癥和術後早期功能.結果:隨訪時間為1~44箇月,平均8.74箇月.兩組患者手術時間(P=0.173)、圍手術期併髮癥(χ2=0.014, P=0.905)和術後早期功能(P=0.777)等圍手術期指標無統計學差異.髓內針/接骨闆內固定組1例于術後3週死于多器官衰竭,假體置換組患者術中齣血量顯著低于髓內針/接骨闆內固定組(P=0.043).結論:假體置換和髓內針/接骨闆內固定均為股骨近耑轉移癌的重要手術方式,兩種重建方法的圍手術期併髮癥和術後早期功能無統計學差異,但鑒于髓內針/接骨闆內固定的遠期失敗率較高,對預期生存期較長的患者來說,假體置換是更好的選擇.
고골근단전이암절제중건방법적선택수요종합고필다충인소,기중원발종류적생물학행위、고골병변파배범위、환자일반상황이급위수술기풍험시최치득관주적.목적:비교고골근단전이암환자접수수내침/접골판내고정화가체치환적위수술기안전성화조기공능.방법:회고성분석2003년1월지2011년12월접수수술치료적88례고골근단전이성종류환자적위수술기림상자료(수방자료완정),년령15~87세,중위년령58세.환자평균예기생존기10.26개월.안수술중건방식분위수내침/접골판내고정조33례;가체치환조55례.비교량조환자적술중출혈량、수술시간、위수술기병발증화술후조기공능.결과:수방시간위1~44개월,평균8.74개월.량조환자수술시간(P=0.173)、위수술기병발증(χ2=0.014, P=0.905)화술후조기공능(P=0.777)등위수술기지표무통계학차이.수내침/접골판내고정조1례우술후3주사우다기관쇠갈,가체치환조환자술중출혈량현저저우수내침/접골판내고정조(P=0.043).결론:가체치환화수내침/접골판내고정균위고골근단전이암적중요수술방식,량충중건방법적위수술기병발증화술후조기공능무통계학차이,단감우수내침/접골판내고정적원기실패솔교고,대예기생존기교장적환자래설,가체치환시경호적선택.
@@@@Background:Selecting the reconstruction method for resection of the metastases of proximal femur needs an overall consid-eration of various factors, among which the biological behavior of the primary tumor, the damage scope of the fumer lesion, the general condition of the patient, and the perioperative risk deserve the most consideration. Objective:To compare the perioperative safety and early function of the intramedullary nail/plate internal fixation and the prosthesis replacement in treating patients with metastases of proximal femur. Methods:The perioperative clinical data (the follow-up data is complete) of 88 patients with proximal femoral metastatic le-sions who received surgical treatment in Peking University People's Hospital from January 2003 to December 2011 was ret-rospectively analyzed. The age of these patients varied from 15 to 87 years old, with a median age of 58. The mean estimat-ed survival time was 10.26 months. Classified by the reconstruction method, the patients were divided into two groups:the intramedullary nail/plate internal fixation group (33 cases) and the prosthesis replacement group (55 cases). The periopera-tive blood loss, the duration of the surgery, the perioperative complications, and the postoperative early functions of the two groups were compared. Results:The mean follow-up period was 8.74 months (1-44 months). Perioperative factors such as the duration of the sur-gery (P=0.173), perioperative complications (χ2=0.014, P=0.905), and the postoperative early functions (P=0.777) of the two groups showed no significant difference. One case in the intramedullary nail/plate internal fixation group died of multi-ple organ failure 3 weeks later after the surgery. The blood loss of the prosthesis replacement group was significantly less than the intramedullary nail/plate internal fixation group (P=0.043). Conclusions:Both prosthesis replacement and intramedullary nail/plate internal fixation are important operation methods in treating the metastases of proximal femur. These two reconstruction methods have no significant differences in the perioper-ative complications and the postoperative early functions. However, as the intramedullary nail/plate internal fixation has a higher future failure rate, it is better to select the prosthesis replacement for patients with an estimated longer survival time.